Bérénice Robert in La Recherche quarterly no. 583
October-December 2025

Nuclear medicine is a fertile ground for start-ups. One of the most promising sectors in this field is targeted radionuclide therapy and alpha therapies. These breakthrough approaches are generating growing interest and investments, as they could enable the treatment of cancers that have until now been difficult to eradicate.

Reference

Source: La Recherche, quarterly no. 583, October-December 2025

Author: Bérénice Robert

Link to original article: www.larecherche.fr